Marco Sciveres

Dr. Marco Sciveres

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2008 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
SCSilvia Caprai
Silvia Caprai
Pietro VajroPietro Vajro
Pietro Vajro
AValessandro ventura
alessandro ventura
MSMarco Sciveres
Marco Sciveres
GMGiuseppe Maggiore
Giuseppe Maggiore
SDSIGENP Study Group for Autoimmune Liver Disorders in Celiac Disease
SIGENP Study Group for Autoimmune Liver Disorders in Celiac Disease

1 November 2010 in Journal of Hepatology
Verified
Journal Article
Open access
GMGiuseppe Maggiore
Giuseppe Maggiore
EGEmmanuel GONZALES
Emmanuel GONZALES
MSMarco Sciveres
Marco Sciveres
MRMarie-José Redon
Marie-José Redon
BGBrigitte Grosse
Brigitte Grosse
EJEmmanuel Jacquemin
Emmanuel Jacquemin
PFIC2 is caused by mutations in ABCB11 encoding BSEP. In most cases affected children need liver transplantation that is thought to be curative. We report on two patients who developed recurrent normal GGT cholestasis mimicking primary BSEP disease, after liver transplantation. PFIC2 diagnosis was made in infancy in both patients on absence of canalicular BSEP immunodetection and on ABCB11 mutation identification. Liver transplantation was performed at age 9 (patient 1) and 2.8 (patient 2) years without major complications. Cholestasis with normal GGT developed 17 and 4.8years after liver transplantation, in patient 1 and patient 2, respectively, during an immunosuppression reduction period. Liver biopsies showed canalicular cholestasis, giant hepatocytes, and slight lobular fibrosis, without evidence of rejection or biliary complications. An increase in immunosuppression resulted in cholestasis resolution in only one patient. Both patients developed atrial fibrillation, and one melanonychia. The newborn of patient 1 developed transient neonatal normal GGT cholestasis. Immunofluorescence staining of normal human liver sections with patient's sera, collected at the time of cholestasis, and using an anti-human IgG antibody to detect serum antibodies, showed reactivity to a canalicular epitope, likely to be BSEP. Indeed, Western blot analysis showed that patient 2 serum recognized rat Bsep. Allo-immune mediated BSEP dysfunction may occur after liver transplantation in PFIC2 patients leading to a PFIC2 like phenotype. Extrahepatic features and/or offspring transient neonatal cholestasis of possible immune mediated mechanisms, may be associated. Increasing the immunosuppressive regimen might be an effective therapy.

1 July 2016 in Digestive and Liver Disease
Verified
Journal Article
Closed access
GMGiuseppe Maggiore
Giuseppe Maggiore
GSGérard Socie
Gérard Socie
MSMarco Sciveres
Marco Sciveres
ARAnne-Marie Roque-Afonso
Anne-Marie Roque-Afonso
SNSilvia Nastasio
Silvia Nastasio
OBOlivier Bernard
Olivier Bernard

1 March 2017 in Cancer Letters
Verified
Journal Article
Open access
AGAlessia Gallo
Alessia Gallo
SVSerena Vella
Serena Vella
MMMonica Miele
Monica Miele
FTFrancesca Timoneri
Francesca Timoneri
MBMariangela Di Bella
Mariangela Di Bella
PCPier Giulio Conaldi
Pier Giulio Conaldi
The human EBV-transformed lymphoblastoid cell line (LCL), obtained by infecting peripheral blood monocular cells with Epstein-Barr Virus, has been extensively used for human genetic, pharmacogenomic, and immunologic studies. Recently, the role of exosomes has also been indicated as crucial in the crosstalk between EBV and the host microenvironment. Because the role that the LCL and LCL exosomal cargo might play in maintaining persistent infection, and since little is known regarding the non-coding RNAs of LCL, the aim of our work was the comprehensive characterization of this class of RNA, cellular and viral miRNAs, and cellular lncRNAs, in LCL compared with PBMC derived from the same donors. In this study, we have demonstrated, for the first time, that all the viral miRNAs expressed by LCL are also packaged in the exosomes, and we found that two miRNAs, ebv-miR-BART3 and ebv-miR-BHRF1-1, are more abundant in the exosomes, suggesting a microvescicular viral microRNA transfer. In addition, lncRNA profiling revealed that LCLs were enriched in lncRNA H19 and H19 antisense, and released these through exosomes, suggesting a leading role in the regulation of the tumor microenvironment.

1 July 2011 in The Journal of Pediatrics
Verified
Journal Article
Closed access
GMGiuseppe Maggiore
Giuseppe Maggiore
MSMarco Sciveres
Marco Sciveres
MFMonique Fabre
Monique Fabre
LGLaura Gori
Laura Gori
LPLucia Pacifico
Lucia Pacifico
OBOlivier Bernard
Olivier Bernard

1 October 2015 in The Journal of Pediatrics
Verified
Journal Article
Closed access
MPMassimiliano Paganelli
Massimiliano Paganelli
JLJosé E. Lipsich
José E. Lipsich
MSMarco Sciveres
Marco Sciveres
FAFernando Alvarez
Fernando Alvarez